Zoetis grants RSUs and options to EVP Esch
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Kevin Esch received new equity awards on February 18, 2026. He was granted 4,026 restricted stock units and 15,931 stock options at a price of $0 per unit or option. Each RSU represents a contingent right to one Zoetis common share.
One-third of each RSU and one-third of each option will vest on the first, second, and third anniversaries of the grant date, February 18, 2026, subject to his continued service and possible earlier vesting upon certain specified events. Each option expires on the tenth anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 19,957 shares
Grant/Award
9 txns
Insider
Esch Kevin
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 4,026 | $0.00 | $0.00 |
| Grant/Award | Stock Option | 15,931 | $0.00 | $0.00 |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 5,153.0022 contracts for 1,127.0022 underlying shares (Direct);
Stock Option — 18,538 contracts for 2,607 underlying shares (Direct)
Footnotes (15)
- F1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
- F2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
- F3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
- F4. Not applicable.
- F5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, April 30, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
- F6. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
- F7. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
- F8. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
- F9. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
- F10. Each option expires on the tenth anniversary of the date of grant.
- F11. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
- F12. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
- F13. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
- F14. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
- F15. Each option vested on the third anniversary of the date of grant, February 8, 2022.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Zoetis (ZTS) Executive Vice President Kevin Esch receive in this Form 4 filing?
Kevin Esch received equity awards consisting of 4,026 restricted stock units and 15,931 stock options. These awards were granted under Zoetis’ equity and incentive plan and are structured to vest over three years, aligning his compensation with long-term company performance and service.
How do the restricted stock units granted to Kevin Esch at Zoetis (ZTS) work?
Each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. One-third of each RSU will vest on the first, second, and third anniversaries of the February 18, 2026 grant date, assuming continued service and subject to earlier vesting events.
What are the vesting terms of the stock options granted to Kevin Esch at Zoetis (ZTS)?
The 15,931 stock options vest in three equal installments. One-third of each option vests on the first, second, and third anniversaries of the February 18, 2026 grant date, and each option expires on the tenth anniversary of that grant date, if not exercised earlier.
Is there any purchase price for Kevin Esch’s new Zoetis (ZTS) RSUs and options?
The Form 4 shows a transaction price per unit or option of $0. This reflects that the RSUs and stock options are granted as part of compensation rather than bought in the open market, with value realized later through vesting and potential option exercise.
What conditions affect vesting of Kevin Esch’s equity awards at Zoetis (ZTS)?
Vesting of both RSUs and options depends on Kevin Esch’s continued service through each vesting date. The awards may also vest earlier upon certain specific events described in the plan, providing potential acceleration under defined circumstances such as qualifying corporate or employment events.
How long do the newly granted Zoetis (ZTS) stock options to Kevin Esch remain exercisable?
Each stock option granted to Kevin Esch expires on the tenth anniversary of the February 18, 2026 grant date. After that tenth anniversary, any unexercised options lapse, meaning they can no longer be exercised for Zoetis common shares under the terms disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
